Titan Pharmaceuticals

NASDAQ

TTNP

$6.90 0.08 1.16%

Today share price

USA

Sector: Healthcare Industry: Pharmaceuticals

Get access
to the rating of Finrange stocks

With this tariff you will be able to use the service without restrictions, all information will be available

Get 7 days free

51.98M

45.77M

0.86

7.53M

1,572.70 %

Indicator	Company	Industry
P/E (LTM) Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months. More	-9.37	8.79
P/BV (LTM) Shows the ratio of the market price of the share to the current book value. More	7.83	25.38
EV/EBITDA (LTM) Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months. More	-6.39	4.40
Net Debt/EBITDA (LTM) A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt. More	0.87	0.50
ROE (LTM) Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months. More	-83.51	9.54

1.67$ 6.63$

Min Max

Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on the treatment for chronic diseases. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program, TP-2021 for use in combination with ProNeura technology for treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including non-clinical evaluation of the ProNeura platform in malaria prophylaxis. Titan Pharmaceuticals, Inc. was incorporated in 1992 and is based in South San Francisco, California.

Address:

400 Oyster Point Boulevard, South San Francisco, CA, United States, 94080

Company name:

Titan Pharmaceuticals

Issuer ticker: TTNP

ISIN: US8883146065

Country: USA

Exchange: NASDAQ

Currency: $

IPO date: 1996-01-18

Sector: Healthcare

Industry: Pharmaceuticals

Site:

https://www.titanpharm.com

On which stock exchange are Titan Pharmaceuticals (TTNP) stocks traded?

Titan Pharmaceuticals (TTNP) stocks are traded on NASDAQ.

What is the ticker of Titan Pharmaceuticals stocks (TTNP)?

The stock ticker of Titan Pharmaceuticals’s stocks or in other words, the code is TTNP. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Titan Pharmaceuticals (TTNP) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Titan Pharmaceuticals (TTNP) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Titan Pharmaceuticals (TTNP) stocks traded?

Titan Pharmaceuticals (TTNP) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Titan Pharmaceuticals (TTNP) stocks today?

The current price of Titan Pharmaceuticals stocks on 14.05.2024 is 6.8999 dollars. per share.

What is the dynamics of Titan Pharmaceuticals (TTNP) stocks from the beginning of the year?

Titan Pharmaceuticals (TTNP) quotes have increased by 1572.7% from the beginning of the year up to 6.8999 dollars. per 1 stocks.

How much did Titan Pharmaceuticals (TTNP) stocks increase in мае 2024?

This month Titan Pharmaceuticals (TTNP) quotes have increased by 2.98% to 6.8999 dollars. per share.

How much are Titan Pharmaceuticals (TTNP) stocks worth?

Today, on October, 14.05.2024 Titan Pharmaceuticals’s (TTNP) stocks cost 6.8999 dollars..

What is the market capitalization of Titan Pharmaceuticals (TTNP)?

Capitalization is the market value of Titan Pharmaceuticals (TTNP) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 14.05.2024, the market capitalization of Titan Pharmaceuticals (TTNP) is estimated at about 51977913 dollars.

Titan Pharmaceuticals

Rating Finrange

Upcoming events Titan Pharmaceuticals

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Titan Pharmaceuticals

Stock analysis Titan Pharmaceuticals

Price change Titan Pharmaceuticals per year

Summary analysis Titan Pharmaceuticals

Shareholder structure Titan Pharmaceuticals

Revenue and net income Titan Pharmaceuticals

Stock news Titan Pharmaceuticals